Document is current
Any future updates will be listed below
-
Authors
Packer, Milton https://orcid.org/0000-0003-1828-2387
- License Information
-
More Information
Article History
Accepted: 29 November 2022
First Online: 6 January 2023
Competing interests
: During the past 3 years, M.P. has received consulting fees from AbbVie, Actavis, Amarin, Amgen, AstraZeneca, Boehringer Ingelheim, Caladrius, Casana, CSL Behring, Cytokinetics, Imara, Lilly, Moderna, Novartis, Reata, Relypsa and Salamandra, entirely related to the design and execution of clinical trials.
